GGrantIndex
← Leaderboards

Focco Van Den Akker

Case Western Reserve University

$5,732,564
Attributed
$5,732,564
Total exposure
14
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $573.8K · FY200524
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$5,732,564 · 14

By mechanism

R01$3,797,890 · 2
R21$1,642,355 · 4
R56$270,375 · 1
P41$21,944 · 7

Top collaborators

No co-investigators on record.

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Structure

Research focus

StructureDesignAntibioticsCrystallographyComplexLeadBinding (Molecular Function)Inhibitor/AntagonistMolecularBeta-LactamaseInsightCarbapenemsResistanceSignal TransductionProteinsLinkAntibiotic ResistanceResortStructural BiologyBacterial InfectionsResearch PersonnelShapesNovel TherapeuticsMembrane

Grant awards (28)

Developing novel pyrazolidinone antibiotics targeting PBP3 to overcome resistance mechanisms$201,250
R21 · FY2024 · AI · contact PI
Developing novel pyrazolidinone antibiotics targeting PBP3 to overcome resistance mechanisms$241,500
R21 · FY2023 · AI · contact PI
Targeting Escherichia coli PBP1b using fragment-based approaches$241,500
R21 · FY2022 · AI · contact PI
Small molecule inhibitors of lytic transglycosylase to potentiate beta-lactam antibiotics$210,105
R21 · FY2021 · AI · contact PI
Targeting Escherichia coli PBP1b using fragment-based approaches$201,250
R21 · FY2021 · AI · contact PI
Small molecule inhibitors of lytic transglycosylase to potentiate beta-lactam antibiotics$240,750
R21 · FY2020 · AI · contact PI
Soluble guanylyl cyclase: mechanisms of activation and modulation$384,650
R01 · FY2014 · HL · contact PI
Soluble guanylyl cyclase: mechanisms of activation and modulation$373,660
R01 · FY2013 · HL · contact PI
Soluble guanylyl cyclase: mechanisms of activation and modulation$392,500
R01 · FY2012 · HL · contact PI
Soluble guanylyl cyclase: mechanisms of activation and modulation$392,500
R01 · FY2011 · HL · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE PROTEINS AND SIGNAL TRANSDUCTI$1,368
P41 · FY2011 · RR · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE PROTEINS AND SIGNAL TRANSDUCTI$559
P41 · FY2011 · RR · contact PI
Mechanistic studies and inhibition strategies for antibiotic resistance$262,585
R01 · FY2010 · AI · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE PROTEINS AND SIGNAL TRANSDUCTI$3,735
P41 · FY2010 · RR · contact PI
Mechanistic studies and inhibition strategies for antibiotic resistance$265,238
R01 · FY2009 · AI · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE PROTEINS AND SIGNAL TRANSDUCTI$2,067
P41 · FY2009 · RR · contact PI
Mechanism of activation of natriuretic peptide receptors$292,988
R01 · FY2008 · HL · contact PI
Mechanistic studies and inhibition strategies for antibiotic resistance$265,238
R01 · FY2008 · AI · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE AND SIGNAL TRANSDUCTION$4,882
P41 · FY2008 · RR · contact PI
Mechanism of activation of natriuretic peptide receptors$292,988
R01 · FY2007 · HL · contact PI
Mechanistic studies and inhibition strategies for antibiotic resistance$270,375
R01 · FY2007 · AI · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE AND SIGNAL TRANSDUCTION$3,852
P41 · FY2007 · RR · contact PI
Mechanism of activation of natriuretic peptide receptors$301,739
R01 · FY2006 · HL · contact PI
CRYSTALLOGRAPHIC STUDIES OF ANTIBIOTIC RESISTANCE AND SIGNAL TRANSDUCTION$5,481
P41 · FY2006 · RR · contact PI
Mechanism of activation of natriuretic peptide receptors$303,429
R01 · FY2005 · HL
Molecular mechanisms of antibiotic resistance$270,375
R56 · FY2005 · AI
Atrial natriuretic peptide receptor crystallization$153,000
R21 · FY2004 · DK
Atrial natriuretic peptide receptor crystallization$153,000
R21 · FY2003 · DK